scholarly journals Efficacy of unilateral hemilaminectomy for intraspinal tumor resection: a systematic review and meta-analysis

2020 ◽  
Vol 9 (5) ◽  
pp. 84-84
Author(s):  
Deqiang Lei ◽  
Yinchun Zhou ◽  
Dongxiao Yao ◽  
Fangcheng Zhang ◽  
Xuan Wang ◽  
...  
Radiology ◽  
2021 ◽  
pp. 204723
Author(s):  
Licia P. Luna ◽  
Farzaneh Ghazi Sherbaf ◽  
Haris I. Sair ◽  
Debraj Mukherjee ◽  
Isabella Bezerra Oliveira ◽  
...  

2019 ◽  
Vol 43 (7) ◽  
pp. 1829-1840 ◽  
Author(s):  
Constantinos Simillis ◽  
Eliana Kalakouti ◽  
Thalia Afxentiou ◽  
Christos Kontovounisios ◽  
Jason J. Smith ◽  
...  

2018 ◽  
Vol 44 (10) ◽  
pp. 1504-1512 ◽  
Author(s):  
Weikai Xiao ◽  
Yutian Zou ◽  
Shaoquan Zheng ◽  
Xiaoqian Hu ◽  
Peng Liu ◽  
...  

2016 ◽  
Vol 175 (4) ◽  
pp. R135-R145 ◽  
Author(s):  
Laurence Amar ◽  
Charlotte Lussey-Lepoutre ◽  
Jacques W M Lenders ◽  
Juliette Djadi-Prat ◽  
Pierre-Francois Plouin ◽  
...  

Objectives To systematically review the incidence and factors associated with recurrences or new tumors after apparent complete resection of pheochromocytoma or thoraco–abdomino–pelvic paraganglioma. Design A systematic review and meta-analysis of published literature was performed. Methods Pubmed and Embase from 1980 to 2012 were searched for studies published in English on patients with non-metastatic pheochromocytoma or thoraco–abdomino–pelvic paraganglioma, complete tumor resection, postoperative follow-up exceeding 1 month, and recurrence or new tumor documented by pathology, hormonal dosages, or imaging tests. Incidence rates of new events after curative surgery were calculated for each study that had sufficient information and pooled using random-effect meta-analysis. Results In total, 38 studies were selected from 3518 references, of which 36 reported retrospective cohorts from the USA, Europe, and Asia. Patient follow-up was neither standardized nor exhaustive in the included studies. A clear description of patient retrieval methods was available for nine studies and the follow-up protocol and patient flow for four studies. Only two studies used multivariable methods to assess potential predictors of postoperative events. The overall rate of recurrent disease from 34 studies was 0.98 events/100 person-years (95% confidence interval 0.71, 1.25). Syndromic diseases and paragangliomas were consistently associated with a higher risk of a new event in individual studies and in meta-regression analysis. Conclusions The risk of recurrent disease after complete resection of pheochromocytoma may be lower than that previously estimated, corresponding to five events for 100 patients followed up for 5 years after complete resection. Risk stratification is required to tailor the follow-up protocol after complete resection of a pheochromocytoma or paraganglioma. Large multicenter studies are needed to this end.


2021 ◽  
Vol 9 ◽  
Author(s):  
Yingyi Qi ◽  
Jianghua Zhan

Purpose: Neuroblastoma is the most common extracranial solid tumor in children, and most patients are at high risk when they are initially diagnosed. The roles of surgery and induction chemotherapy in patients with high-risk neuroblastoma have been a subject of much controversy and debate. The objective of the current study was to assess the roles of surgery in high-risk neuroblastoma.Method: The review protocol was prospectively registered (PROSPEROID: CRD42021253961). The PubMed, Embase, Cochrane, and CNKI databases were searched from inception to January 2020 with no restrictions on language or publication date. Clinical studies comparing the outcomes of different surgical ranges for the treatment of high-risk neuroblastoma were analyzed. The Mantel–Haenszel method and a random effects model was utilized to calculate the hazard ratio (95% CI).Results: Fourteen studies that assessed 1,915 subjects met the full inclusion criteria. Compared with the gross tumor resection (GTR) group, complete tumor resection (CTR) did not significantly improve the 5-year EFS [p = 1.0; HR = 0.95 (95% CI, 0.87–1.05); I2 = 0%], and the 5-year OS [p = 0.76; HR = 1.08 (95% CI, 0.80–1.46); I2 = 0%] of patients. GTR or CTR resection had significantly better 5-year OS [p = 0.45; HR = 0.56 (95% CI, 0.43–0.72); I2 = 0%] and 5-year EFS [p = 0.15; HR = 0.80 (95% CI, 0.71–0.90); I2 = 31%] than subtotal tumor resection (STR) or biopsy only; however, both CTR or GTR showed a trend for more intra and post-operative complications compared with the STR or biopsy only [p = 0.37; OR = 1.54 (95% CI, 1.08–2.20); I2 = 0%]. The EFS of the patients who underwent GTR or CTR at the time of diagnosis and after induction chemotherapy were similar [p = 0.24; HR = 1.53 (95% CI, 0.84–2.77); I2 = 29%].Conclusion: For patients with high-risk neuroblastoma, complete tumor resection and gross tumor resection of the primary tumor were related to improved survival, with very limited effects on reducing intraoperative and postoperative complications. It is necessary to design strong chemotherapy regimens to improve the survival rate of advanced patients.Systematic Review Registration:https://www.crd.york.ac.uk/PROSPERO/, PROSPEROID [CRD42021253961].


2018 ◽  
Vol 18 (4) ◽  
pp. e595-e600 ◽  
Author(s):  
Susan G. Brouwer de Koning ◽  
Marie-Jeanne T.F.D. Vrancken Peeters ◽  
Katarzyna Jóźwiak ◽  
Patrick A. Bhairosing ◽  
Theo J.M. Ruers

2020 ◽  
Vol 162 (11) ◽  
pp. 2595-2617
Author(s):  
Daniele Starnoni ◽  
Lorenzo Giammattei ◽  
Giulia Cossu ◽  
Michael J. Link ◽  
Pierre-Hugues Roche ◽  
...  

Abstract Background and objective The optimal management of large vestibular schwannomas continues to be debated. We constituted a task force comprising the members of the EANS skull base committee along with international experts to derive recommendations for the management of this problem from a European perspective. Material and methods A systematic review of MEDLINE database, in compliance with the PRISMA guidelines, was performed. A subgroup analysis screening all surgical series published within the last 20 years (January 2000 to March 2020) was performed. Weighted summary rates for tumor resection, oncological control, and facial nerve preservation were determined using meta-analysis models. This data along with contemporary practice patterns were discussed within the task force to generate consensual recommendations regarding preoperative evaluations, optimal surgical strategy, and follow-up management. Results Tumor classification grades should be systematically used in the perioperative management of patients, with large vestibular schwannomas (VS) defined as > 30 mm in the largest extrameatal diameter. Grading scales for pre- and postoperative hearing (AAO-HNS or GR) and facial nerve function (HB) are to be used for reporting functional outcome. There is a lack of consensus to support the superiority of any surgical strategy with respect to extent of resection and use of adjuvant radiosurgery. Intraoperative neuromonitoring needs to be routinely used to preserve neural function. Recommendations for postoperative clinico-radiological evaluations have been elucidated based on the surgical strategy employed. Conclusion The main goal of management of large vestibular schwannomas should focus on maintaining/improving quality of life (QoL), making every attempt at facial/cochlear nerve functional preservation while ensuring optimal oncological control, thereby allowing to meet patient expectations. Despite the fact that this analysis yielded only a few Class B evidences and mostly expert opinions, it will guide practitioners to manage these patients and form the basis for future clinical trials.


Sign in / Sign up

Export Citation Format

Share Document